Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEFLUNOMIDE vs LENVATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEFLUNOMIDE vs LENVATINIB: Safety Overview

Metric LEFLUNOMIDE LENVATINIB
Total FAERS Reports 56,539 33,766
Deaths Reported 5,283 4,449
Death Rate 9.3% 13.2%
Hospitalizations 13,923 19,975
Average Patient Age 51.3 yrs 65.4 yrs
% Female Patients 87.3% 55.8%
FDA Approval Date Apr 24, 2019 Feb 13, 2015
Manufacturer Alembic Pharmaceuticals Inc. Eisai Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription